Calidi Biotherapeutics Inc (AMEX:CLDI) traded at $0.57 at close of the session on Tuesday, July 15 and made a downward move of -1.21% on its previous day’s price.
Looking at the stock we see that its previous close was $0.58 and the beta (5Y monthly) reads 1.06 with the day’s price range being $0.48 – $0.5749. In terms of its 52-week price range, CLDI has a high of $3.89 and a low of $0.20. The company’s stock has gained about 66.57% over that past 30 days.
Calidi Biotherapeutics Inc has a market cap of $19.75 million and is expected to release its quarterly earnings report on 2025-May-14.
On the other hand, looking at the outlook for the CLDI stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Sell.
Looking further, we note the current price level is 51.39% off its SMA20 and 46.95% from its 50-day simple moving average. The RSI (14) is pointing at 57.27 while the volatility over the past week is 61.47% and jumps to 25.73% over the past one month. The average price target for the stock over the next 12 months is $5.5, with the estimates having a low of $2 and a high of $9. These price ends are -250.88% and -1478.95% off the current price level respectively, although investors could be excited at the prospect of a -864.91% if the CLDI share price touches on the median price of $5.5.
Coming back to Calidi Biotherapeutics Inc (AMEX:CLDI), we note that the average 3-month trading volume was 13.99 million, while that of the preceding 10-day period stands at 81.02 million. Current shares outstanding are 34.52 million.
The insiders hold 6.57% of the company’s shares while institutions hold 15.78%. The data shows that short shares as of 2025-06-13, stood at 0.37 million at a short ratio of 0.74. This represents a 126.00 short interest in shares outstanding on 2025-06-13. Shares short rose in June from the previous month at 0.27 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -62.27% down in year-to-date price movement.
